4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-012273
Options or other derivatives
- Chief Commercial Officer acquired 305,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kirby Daniel Gordon Chief Commercial Officer | 2025-02-10 | Grant or award · Stock Options (Right to Buy) | +35,000 | 35,000 | D | ||
| Kirby Daniel Gordon Chief Commercial Officer | 2025-02-10 | Grant or award · Restricted Stock Units | +120,000 | 120,000 | D | ||
| Kirby Daniel Gordon Chief Commercial Officer | 2025-02-10 | Grant or award · Performance Stock Units | +150,000 | 150,000 | D | ||
Loading xslF345X05/tm256127d2_4seq1.xml…